Protocol for producing hyperpolarized 13C-bicarbonate for clinical MRI of extracellular pH in aggressive tumors

STAR Protoc. 2024 Sep 20;5(3):103091. doi: 10.1016/j.xpro.2024.103091. Epub 2024 Jun 28.

Abstract

Tumor acidosis is one of the hallmarks indicating the initiation and progression of various cancers. Here, we present a protocol for preparing a hyperpolarized (HP) 13C-bicarbonate tissue pH MRI imaging contrast agent to detect aggressive tumors. We describe the steps for the formulation and polarization of a precursor molecule 13C-glycerol carbonate (13C-GLC), the post-dissolution reaction, and converting HP 13C-GLC to an injectable HP 13C-bicarbonate solution. We then detail procedures for MRI data acquisition to generate tumor pH maps for assessing tumor aggressiveness. For complete details on the use and execution of this protocol, please refer to Mu et al.1.

Keywords: Biotechnology and bioengineering; Cancer; Chemistry; Clinical Protocol; Health Sciences; Metabolism; Molecular/Chemical Probes.

MeSH terms

  • Animals
  • Bicarbonates* / metabolism
  • Carbon Isotopes* / chemistry
  • Contrast Media / chemistry
  • Humans
  • Hydrogen-Ion Concentration
  • Magnetic Resonance Imaging* / methods
  • Mice
  • Neoplasms / diagnostic imaging
  • Neoplasms / metabolism

Substances

  • Bicarbonates
  • Carbon Isotopes
  • Contrast Media
  • Carbon-13